Sandoz, Teva announce availability of generic Cipro

IRVINE, Calif. & PRINCETON, N.J. Sandoz and Teva have introduced their newest product, Ciprofloxacin injection, a generic version of Bayer’s antibiotic, Cipro.

The drug will be available in 2 mg/mL, 200 mg and 2 mg/mL, 200 mg. Teva is marketing the drug in flexible plastic containers and Sandoz will use mini-bags.

According to IMS data, sales of injectable ciprofloxacin in the United States in 2006 were approximately $60 million.